Current Report Filing (8-k)
2021年6月16日 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported: June 15, 2021
TARGET GROUP INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
000-55066
|
46-3621499
|
State or other jurisdiction incorporation
|
Commission File Number
|
IRS Employer Identification No.
|
20
Hempstead Drive, Hamilton, Ontario, Canada
|
L8W
2E7
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (905) 541-3833
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company x
For an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Emerging Growth Company ¨
Securities registered pursuant to Section 12(b) of the Securities
Exchange Act of 1934:
Title of each class
|
|
Trading symbol
|
|
Name of each exchanges on which registered
|
|
|
|
|
|
N/A
|
|
N/A
|
|
N/A
|
Section 7- Regulation FD
|
Item 7.01
|
Regulation FD Disclosure
|
On June 15, 2021, the Company
distributed a newsletter to its shareholders announcing that its wholly owned subsidiary, CanaryRx Inc., has received its Health Canada
sales license which will permit Canary Rx Inc. to manufacture and sell cannabis products directly to provincial distributors and other
authorized Canadian retail supply channels.
A copy of the newsletter is
attached as an exhibit to this Report and is incorporated herein by this reference.
Section 9- Financial Statements and Exhibits
|
Item 9.01
|
Financial Statements and Exhibits
|
Signature
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TARGET GROUP INC.
|
|
|
|
Dated: June 15, 2021
|
By:
|
/s/ Anthony Zarcone
|
|
Chief Executive Officer
|
Target (PK) (USOTC:CBDY)
過去 株価チャート
から 5 2024 まで 6 2024
Target (PK) (USOTC:CBDY)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Target Group Inc (PK) (その他OTC): 0 recent articles
その他のTarget Group Inc.ニュース記事